Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
23.63%
Operating Margin
7.90%
Net Margin
4.18%
Efficiency Metrics
Revenue per Expense Ratio
1.09
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
11.72%
Income Tax Rate
18.85%
EPS
1.0100000000
Balance Sheet Analysis
Current Ratio
2.21
Cash Ratio
0.20
Working Capital
$143.72M
Debt to Equity
1.11
Debt to Assets
41.57%
Equity Ratio
37.50%
Cash Flow Analysis
Operating Cash Flow Ratio
2.14%
Free Cash Flow Ratio
0.28%
CapEx to Revenue
1.85%
Dividends Paid
$27.44M
Stock Buybacks
No buybacks
Total Shareholder Returns
$27.44M
Cash Position Change
16.87%
Key Takeaways (2023 FY)
Revenue declined by 7.7734925365382%, indicating potential market challenges
Increased dividend payments by 1.33%
Detailed Growth Metrics
Core Performance
Revenue
-7.77%
Net Income
-38.56%
EPS
-38.79%
Operating Income
-23.56%
Operational Efficiency
R&D Expenses
-17.09%
SG&A Expenses
-4.07%
Operating Cash Flow
-68.85%
Free Cash Flow
-93.04%
Balance Sheet Health
Assets
-0.58%
Debt
13.32%
Book Value per Share
-2.54%
Inventory
3.55%
Shareholder Returns
Dividends per Share
1.33%
Shares Outstanding
0.21%
Long Term Trends
3Y Revenue/Share
17.73%
5Y Revenue/Share
7.09%
3Y Dividend/Share
5.31%
5Y Dividend/Share
11.17%